Taro pharmaceutical industries ltd (TARO)
Balance Sheet / TTM
Mar'18Mar'17Mar'16Mar'15Mar'14Mar'13Mar'12Dec'11Dec'10
ASSETS
CURRENT ASSETS:
Cash and cash equivalents

576

600

576

481

209

237

238

150

54

Short-term and current maturities of long-term bank deposits

296

782

648

434

-

-

-

-

-

Short-term bank deposits

-

-

-

-

418

312

72

89

31

Restricted short-term bank deposits

-

-

-

0

0

7

15

16

0

Marketable securities

549

3

3

3

3

3

7

2

3

Accounts receivable and other:
Trade, net

206

203

238

222

138

119

111

120

73

Other receivables and prepaid expenses

122

266

270

250

162

119

98

94

49

Inventories

144

141

138

120

117

109

109

107

83

Long-term assets held for sale, net

-

1

1

-

0

0

0

0

0

TOTAL CURRENT ASSETS

1,896

1,999

1,877

1,513

1,051

909

653

581

295

LONG-TERM DEPOSITS AND MARKETABLE SECURITIES

225

70

-

-

-

-

-

-

-

LONG-TERM BANK DEPOSITS

-

-

115

30

-

-

-

-

-

LONG-TERM RECEIVABLES AND OTHER ASSETS

-

-

-

-

52

23

19

23

30

PROPERTY, PLANT AND EQUIPMENT, NET

193

180

159

153

151

145

150

152

163

GOODWILL

-

-

-

-

7

7

7

7

7

INTANGIBLE ASSETS AND DEFERRED COSTS, NET

-

-

-

-

16

15

18

19

22

DEFERRED INCOME TAXES

87

10

-

-

4

5

6

12

36

OTHER ASSETS

29

29

35

40

-

-

-

-

-

TOTAL ASSETS

2,433

2,289

2,188

1,737

1,284

1,106

856

795

556

LIABILITIES AND SHAREHOLDERS EQUITY
CURRENT LIABILITIES:
Short-term bank credit and short-term loans

-

-

-

-

-

-

-

-

14

Current maturities of long-term debt

-

-

-

0

11

11

10

17

13

Accounts payable:
Trade payables

25

16

18

19

20

19

22

23

21

Other current liabilities

190

193

226

289

220

161

164

149

79

TOTAL CURRENT LIABILITIES

215

209

245

310

253

192

198

190

129

LONG-TERM LIABILITIES:
Long-term debt, net of current maturities

-

-

-

4

5

17

27

27

31

Deferred income taxes

3

2

2

1

1

1

2

1

2

Other long-term liabilities

3

3

3

3

2

3

4

4

8

TOTAL LONG-TERM LIABILITIES

7

6

5

10

10

23

34

34

42

COMMITMENTS AND CONTINGENT LIABILITIES

0

0

0

0

0

0

0

0

0

TOTAL LIABILITIES

222

215

250

320

263

215

233

224

171

SHAREHOLDERS EQUITY:
Taro shareholders' equity:
Ordinary shares of NIS 0.0001 par value: Authorized at March 31, 2018 and March 31, 2017: 200,000,000 shares; Issued at March 31, 2018 and March 31, 2017: 45,116,262 shares Outstanding at March 31, 2018 and March 31, 2017: 39,427,515 and 40,513,209 shares, respectively

0

0

0

0

0

0

0

0

0

Founders shares of NIS 0.00001 par value: Authorized, issued and outstanding at March 31, 2018 and March 31, 2017: 2,600 shares

0

0

0

0

0

0

0

0

0

Additional paid-in capital

262

262

262

262

262

261

253

253

244

Accumulated other comprehensive income, net of taxes

-110

-148

-123

-110

-22

16

23

18

24

Treasury stock at March 31, 2018 and March 31, 2017: 5,688,747 and 4,603,053 shares, respectively

610

498

203

194

194

1

1

1

1

Accumulated earnings

2,662

2,451

1,994

1,453

969

609

343

295

113

Taro shareholders' equity

2,205

2,067

1,931

1,411

1,015

886

619

567

381

Non-controlling interest

5

6

6

5

5

4

3

3

3

TOTAL SHAREHOLDERS EQUITY

2,210

2,073

1,937

1,417

1,020

890

622

571

384

TOTAL LIABILITIES AND SHAREHOLDERS EQUITY

2,433

2,289

2,188

1,737

1,284

1,106

856

795

556